CVS Health Expands National Partnership with Arthritis Foundation to Become the Exclusive Specialty Pharmacy 'Partner for Better Living'(SM)

Top of the article

WOONSOCKET, R.I., Oct. 9, 2015 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today, in advance of World Arthritis Day on October 12, the expansion of a national partnership with the Arthritis Foundation to help advance arthritis advocacy, research and patient support. As part of the partnership, CVS/specialty, the specialty pharmacy of CVS Health, will be designated an Arthritis Foundation 'Partner for Better Living'(SM) and be its first and only specialty pharmacy partner. The distinction recognizes CVS/specialty's commitment to helping people with arthritis and joint pain, and builds on the longstanding relationship between the two organizations. CVS/pharmacy is currently the exclusive retail drugstore partner of the Arthritis Foundation.

"Our expanded partnership with the Arthritis Foundation will allow us to extend our purpose of helping people on their path to better health by supporting an organization dedicated to advancing education, access to care, advancements in science and community connections for people with arthritis," said Alan Lotvin, MD, executive vice president of specialty pharmacy for CVS/caremark, the pharmacy benefits manager of CVS Health. "CVS/specialty is a different kind of pharmacy with services that offer convenience, care and support for our patients with complex conditions, like rheumatoid arthritis, so they have the freedom to focus on every part of their lives, not just their condition."

As an Arthritis Foundation 'Partner for Better Living,' CVS/specialty is helping people with certain forms of arthritis take control of managing their complex condition by supporting them with specialized tools, personalized care and convenient access to medications. In fact, the unique model of CVS/specialty is focused on making it easier for patients with a range of complex conditions to start and stay on their prescriptions.

"We're pleased to expand the important work we're doing with CVS Health as the Arthritis Foundation continues to help people living with arthritis conquer every day battles," said Ann M. Palmer, president and chief executive officer of the Arthritis Foundation."We know that access to information and treatment is crucial for people living with arthritis, and with CVS/specialty as a 'Partner for Better Living,' we are now able to better support the millions of Americans with arthritis, including the 1.5 million with rheumatoid arthritis requiring specialty medicines."

CVS/specialty offers the support of a Care Team comprised of pharmacists and nurses who specialize in chronic conditions such as rheumatoid arthritis and insurance specialists who work to find assistance for those with a financial hardship. Patients also have access to personalized specialty infusion care conveniently provided in the home or at an alternative infusion suite. In addition, CVS/specialty simplifies getting started on therapy by offering patients the choice of pickup at their local CVS/pharmacy, or delivery to their home, office or other location. Patients have access to online tools and a free mobile app where they can order refills, track deliveries and get reminders to help them stay on track. For more information about CVS/specialty, visit www.cvsspecialty.com

Since 2014, CVS/pharmacy has been an Arthritis Foundation 'Partner for Better Living' and a one-stop-shop for arthritis-related products, services and resources in-store and online. As part of the partnership, many CVS/pharmacy locations across the country house the Arthritis Solutions Center, which features products and resources to help better support people living with arthritis. By expandingthe national partnership with the Arthritis Foundation, CVS Health can better support the full spectrum of people living with arthritis and joint pain.

About CVS Health
CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through its more than 7,800 retail drugstores, nearly 1,000 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at www.cvshealth.com.

About Arthritis Foundation
The Arthritis Foundation is the Champion of Yes. Leading the fight for the arthritis community, the Foundation helps conquer everyday battles through life-changing information and resources, access to optimal care, advancements in science and community connections. The Arthritis Foundation's goal is to chart a winning course, guiding families in developing personalized plans for living a full life and making each day another stride towards a cure. The Foundation also publishesArthritis Today,the award-winning magazine that reaches 4million readers.

Media Contact:

Christina Beckerman
CVS Health
(401) 770-8868
christina.beckerman@cvshealth.com

Mary Alfieri
CVS Health
401-770-9811
mary.alfieri@cvshealth.com

CVS/specialty and Arthritis Foundation(SM), Partner for Better Living(SM) logo

Logo- http://photos.prnewswire.com/prnh/20140905/143585
Logo - http://photos.prnewswire.com/prnh/20151009/275691LOGO

SOURCE CVS Health

Press Release
"Likes" Count
0

CVS Health Research Institute Study Shows 11.4 Percentage Point Improvement in Medication Adherence Among Patients in Specialty Connect™ Pilot

Top of the article

High cost of specialty drugs makes adherence to therapy more important than ever

WOONSOCKET, R.I., (January 29, 2016) — New research published by the CVS Health (NYSE: CVS) Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect™, CVS Health’s innovative specialty prescription services program. New patients enrolled in the pilot were 17.5 percent more likely to pickup their first refill and existing specialty patients had an 11.4 percentage point improvement in adherence, as compared to a control group. The study was published in the most recent issue of the Journal of the American Pharmacists Association.

“The specialty market is growing rapidly and new high-cost specialty drugs, that were once limited to small patient populations, are now increasingly being indicated to treat many more patients,” said William Shrank, M.D., chief scientific officer and senior vice president, CVS Health. “As new specialty medications are introduced, adherence to therapy will be particularly important to optimize the benefit of these very expensive medications. Specialty Connect, combined with evidence-based benefit design and utilization management strategies, can increase the likelihood that the most appropriate patients receive specialty medications and that, once received, they take them as prescribed.”

CVS Health piloted the Specialty Connect program in 115 CVS Pharmacy stores before launching the program nationwide. Patients enrolled in the pilot could choose to have medications delivered to their home or doctor’s office or opt to pick up their specialty medications at their local CVS Pharmacy, while receiving specialized clinical support from CVS Specialty, the specialty pharmacy of CVS Health. Since the program’s launch, more than 100,000 patients have been served, with more than half choosing to pick up their specialty prescriptions at retail.

Specialty medicines treat complex conditions such as rheumatoid arthritis, multiple sclerosis and hepatitis C. Many of these medications require special handling, storage and administration. In addition, many specialty drugs are only available at select specialty pharmacies to help ensure compliance with required safety and compliance protocols. As a result, patients often have difficulty with the logistics of filling a new prescription for a specialty medication, with as many as one quarter of traditional retail pharmacies unable to fill a specialty prescription without barriers and/or delays. CVS Specialty is the only specialty pharmacy that offers patients a choice of where to get their medicines, either at any CVS Pharmacy location or through mail delivery, which simplifies getting started on a specialty therapy. In addition, the Specialty Care Team provides round-the-clock support and patient care, including symptom management, claims processing and help managing comorbid conditions.

“CVS Specialty is the only specialty pharmacy that integrates rare disease management and coordinated care programs to make it easier for patients to start and stay on complex treatments,” added Alan Lotvin, M.D., president, CVS Specialty and executive vice president, CVS Health. “Since we launched Specialty Connect across all CVS Pharmacy locations, we have seen high rates of adherence, and our specialty patients have reported extremely high satisfaction with their service.”

The CVS Health Research Institute is focused on contributing to the body of scientific knowledge related to pharmacy and health care through research collaborations with external academic institutions, participation in federally-funded research, analysis and sharing of CVS Health data sources and coordination of pilot programs and initiatives. CVS Health Research Institute findings support a continuous quality improvement environment, which encourages product innovation and development to benefit CVS Health patients, clients and their members.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,500 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contacts

Christine Cramer
CVS Health
(401) 770-3317
christine.cramer@cvscaremark.com

Christina Beckerman
CVS Health
(401) 770-8868
christina.beckerman@cvscaremark.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0

CVS Health Statement Regarding Direct and Indirect Remuneration (DIR)

Top of the article

WOONSOCKET, R.I. (February 2, 2017) – CVS Health (NYSE: CVS) today released the following statement regarding Direct and Indirect Remuneration.

The Direct and Indirect Remuneration (DIR) pay-for-performance network program is an important component of the Medicare Part D program created by CMS to help beneficiaries receive higher quality care at a lower cost. It ensures optimal pharmacy performance by driving better clinical performance. Performance network fees being charged to pharmacies are allowed under CMS regulation, and are fully disclosed as part of the annual bid process. CVS Health is not profiting from this program; a change in DIR pay-for-performance networks would not be material to our profitability.

DIR pay-for-performance network fees paid by pharmacies are directly passed to Medicare Part D plan sponsors and are used to lower beneficiary premiums. These fees apply to all participating network pharmacies, including CVS Pharmacy and CVS Specialty. Under Medicare Part D, DIR is fully disclosed to CMS and factored into CMS’s calculation of final Medicare payments to Part D plans. In fact, the DIR reports expressly recognize a plan sponsor’s ability to make retroactive pharmacy payment adjustments based on performance in the DIR reporting.

Congress and CMS over the last 10+ years have incorporated pay-for-performance methodologies into Medicare fee-for-service payment systems. Additionally, Medicare Advantage (MA) plans have pay-for-performance components. Part D plans have mirrored these types of pay-for-performance methodologies, which drive clinical and network performance, because the plans pay the pharmacies directly.

CVS Heath’s profitability would not be materially affected by a change in DIR pay-for- performance networks. If the DIR construct was removed unilaterally, which we view as highly unlikely given Congress and CMS’s movement toward value-based care, all Part D plans would be impacted in the same way. Furthermore, we believe that would lead to higher premiums for beneficiaries across the industry. Congress is supportive of pay-for-performance programs and this is an important tool for the Medicare Part D program to provide higher quality care for beneficiaries at a lower cost.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health.

Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.

Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Investor Contact:

Nancy Christal
(914) 722-4704
Nancy.Christal@CVSHealth.com

Media Contact:

Carolyn Castel
(401) 770-5717
Carolyn.Castel@CVSHealth.com

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
1

CVS Health PBM Clients Achieved Lowest Prescription Drug Trend in Four Years, Despite Rising Drug Prices

Top of the article

CVS Caremark's PBM management solutions helped reduce drug trend from 5.0 percent in 2015 to just 3.2 percent in 2016

Member out-of-pocket costs dropped 3.0 percent

WOONSOCKET, R.I., March 15, 2017 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that, in 2016, its pharmacy benefit management (PBM) clients achieved the lowest drug trend in the past four years, despite rising drug prices. CVS Caremark clients saw their prescription drug trend drop to an average of 3.2 percent compared to 5.0 percent in 2015. In addition, 38 percent of CVS Caremark commercial clients achieved a negative trend which means they actually spent less on their prescription benefit in 2016 than they did in 2015, despite rising drug prices. Out-of-pocket costs for members also dropped 3.0 percent compared to the previous year.

"No one is more concerned about the high cost of prescription drugs than CVS Health," said Troyen Brennan, M.D., Executive Vice President and Chief Medical Officer, CVS Health. "Our very favorable drug trend results for 2016 demonstrate that we have been able to deliver best-in-class value to clients and their members."

Unmanaged drug trend for 2016 was 11.0 percent, driven primarily by price inflation for branded specialty and traditional drugs, as well as increased utilization due to an aging population. CVS Caremark was able to reduce trend for clients by 7.8 percentage points to 3.2 percent through PBM management solutions that include price protection and the negotiation of rebates, of which more than 90 percent are passed back to clients. CVS Caremark also encouraged the use of less expensive generic drugs through managed formularies and applied targeted approaches to addressing high-spend drivers such as hyper-inflating drugs. On average, clients who selected the CVS Caremark standard managed formulary achieved a trend of 2.2 percent, which was less than half the trend of 4.5 percent for clients who used a custom formulary and opted out of drug removals. Additionally, clients who chose our generic-focused value formulary had the highest generic dispensing rate (GDR) at 88.2 percent and the lowest baseline cost at $81.86 per member per month.

Although overall drug price inflation was lower in 2016, it still accounted for almost 80 percent of the unmanaged trend. The relative impact of inflation on specialty branded products continued to increase relative to traditional branded medications. At the same time, overall specialty products grew to nearly 36 percent of overall gross spend. Three of the top five categories contributing to gross trend were specialty drug categories, including anti-inflammatory medications for rheumatoid arthritis and psoriasis; antineoplastics and adjunctive therapies used to treat cancer; and psychotherapeutic and neurological agents, including multiple sclerosis therapies. Meanwhile, generic utilization growth kept costs low for members as well as clients and drove a 3.5 point overall cost reduction for clients.

CVS Caremark offers a variety of solutions, including flexible formulary options based on clinical evidence, to help manage pharmacy costs while ensuring patients have access to the medications they need. In addition, CVS Caremark's strategic assessment of the pharmaceutical marketplace enables the company to negotiate aggressive rebates and help to lower costs for clients. More than 90 percent of brand manufacturer contracts also include price protection, a critical element in protecting clients in a market characterized by significant drug price increases.

Prescription drug trend is the measure of growth in prescription spending per member per month. Trend calculations take into account the effects of drug price, drug utilization and the mix of branded versus generic drugs as well as the positive effect of negotiated rebates on overall trend. The 2016 trend performance is based on a cohort of CVS Health PBM commercial clients employers and health plans.

To learn more about the CVS Caremark 2016 drug trend, click here.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Christine Cramer
CVS Health
(401) 770-3317
christine.cramer@cvshealth.com

Investor Contact

Nancy Christal
CVS Health
(914) 722-4704
nancy.christal@cvshealth.com

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
0

CVS Health's Advanced Care Scripts (ACS) Earns URAC Accreditation for Specialty Pharmacy

Top of the article

The designation demonstrates the highest level of commitment to quality healthcare

WOONSOCKET, R.I., April 4, 2017 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today that Advanced Care Scripts (ACS) has earned accreditation in Specialty Pharmacy from URAC, the independent leader in promoting healthcare quality through accreditation, certification and measurement. By achieving this status, ACS has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.

"We are pleased to receive this accreditation from URAC, which underscores our commitment to providing high-quality care to our patients," said Alan Lotvin, M.D. Executive Vice President of CVS Specialty. "Through our programs and services at ACS, we provide comprehensive, patient-centered care and treatment support for patients taking specialty medications to help improve patient outcomes."

ACS manages and dispenses specialty medications to patients with complex chronic conditions, such as multiple sclerosis, hemophilia and cancer. The comprehensive patient care model of ACS provides compliance and adherence support and cost-effective solutions for all classes of specialty medications.

"It's necessary for specialty pharmacies to provide a higher level of treatment for patients so desired outcomes are achieved. ACS shows a dedication to patient education and safety through the recognition of quality it received with URAC's independent accreditation," said URAC President and CEO Kylanne Green. "With URAC accreditation, people know that ACS strives to adhere to industry best practices."

The URAC accreditation process demonstrates a commitment to quality services and serves as a framework to improve business processes through benchmarking organizations against nationally recognized standards. In addition, a URAC-accredited specialty pharmacy has policies in place to ensure consumers have access to appropriate medications; maintains methods to measure customer satisfaction; and has a patient-centered strategy for its patient management program that includes coordination of care, communication and education, patient rights and responsibilities, among other factors.

About URAC

Founded in 1990, URAC is the independent leader in promoting healthcare quality through accreditation, certification, education, and measurement. URAC is a nonprofit organization developing evidence-based measures and standards through inclusive engagement with a range of stakeholders committed to improving the quality of healthcare. Our portfolio of accreditation and certification programs span the healthcare industry, addressing healthcare management, healthcare operations, health plans, pharmacies, telehealth providers, physician practices, and more. URAC accreditation is a symbol of excellence for organizations to show-case their validated commitment to quality and accountability.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Christina Beckerman
CVS Health
(401) 770 8868
Christina.Beckerman@cvshealth.com

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
0

CVS Health Announces Plans to Focus on Kidney Care and Dialysis Treatment

Top of the article

Company's unique enterprise assets can help improve patient outcomes and control costs

WOONSOCKET, R.I., April 4, 2018 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced a new initiative focused on chronic kidney disease and dialysis, which builds upon the company's focus on driving innovation in the management of chronic disease to help improve patient health outcomes while managing costs. This new program will focus on early identification of kidney disease and expansion of home dialysis in order to optimize care for patients with chronic kidney disease. CVS Health's unique enterprise assets along with the company's introduction of a truly innovative new home hemodialysis technology, position the company as a positive disruptor in the field with the ability to help reshape and redefine the kidney care space.

"In dialysis today, there is an enormous unmet medical need with high levels of mortality, frequent hospitalizations and poor quality of life for affected patients," said Alan Lotvin, M.D., executive vice president and head of CVS Specialty. "As we explored this area it became clear that our enterprise assets from our experience with complex patient home care through Coram, the breadth of our chronic disease management capabilities with CVS Specialty and Accordant, and our deep payor relationships at CVS Caremark will enable us to create a unique value proposition to help reshape dialysis treatment."

CVS Health will be approaching this new initiative in a staged approach with phases focused on early disease identification and patient education, followed by the development of a comprehensive home dialysis program, for both hemodialysis and peritoneal dialysis. As part of the home dialysis program, CVS Health will be initiating a pivotal clinical trial to demonstrate the safety and efficacy of a new home hemodialysis device in support of a planned FDA submission to obtain market clearance. The device has been designed with features intended to make home hemodialysis simple and safe for patients, in order to facilitate longer, more frequent treatments. In published clinical research, longer, more frequent hemodialysis treatments lead to better outcomes in appropriate patient populations.

"Diagnosing kidney disease early is the only way to prevent kidney failure and cardiovascular complications," said Joseph Vassalotti, M.D., chief medical officer, National Kidney Foundation and a board-certified nephrologist. "There is an urgent need to increase patient awareness of not only the disease itself but also of the treatment options available for both early and chronic kidney failure or end-stage renal disease. Many patients believe in-center dialysis is their only kidney failure treatment choice, and do not know about patient-centered options, including home dialysis or kidney transplant," added Dr. Vassalotti.

"While in-center dialysis clinics are currently the most common choice for hemodialysis treatment, published clinical research has shown improved cardiac health, metabolic control, and survival for patients who are treated with longer, more frequent dialysis treatments. This treatment paradigm is best delivered in the convenience of a patient's home," said Bruce Culleton, M.D., vice president and chief medical officer, CVS Specialty. "CVS Health is uniquely positioned to build a solution that will enable us to identify and intervene earlier with patients to optimize the management of chronic kidney disease, while at the same time making home dialysis therapies a real option for more patients."

Nearly 700,000 Americans have End Stage Renal Disease (ESRD), with close to 500,000 of these patients on active dialysis and more than 120,000 new ESRD cases diagnosed each year. Financially, this disease represents a huge cost burden, costing Medicare nearly $65 billion a year for chronic kidney disease care, and another $34 billion directly related to dialysis patient care. Despite this high level of spending, outcomes for Medicare patients treated with traditional in-center hemodialysis, for example, are poor with mortality rates up to 10 times higher than among the general Medicare population.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,800 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 94 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Investor Contact:

Mike McGuire
(401) 770-4050
michael.mcguire@cvshealth.com

Media Contact:

Christine Cramer
(401) 770-3317
christine.cramer@cvshealth.com

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
3
Display Hero
Off
CSR Pillars
Audience

Coram CVS/Specialty Infusion Services Opens New Branch Pharmacy in Richmond, VA

Top of the article

WOONSOCKET, R.I., May 9, 2014 /PRNewswire/ --Coram CVS/specialty infusion services announces the opening of a new branch pharmacy in Richmond, Virginia that will serve the state from Fredericksburg to the North Carolina border, including the Richmond and Norfolk areas. The new facility offers a number of services, including:

Coram Logo
  • Comprehensive offering of infusion therapies, including anti-infective services, parenteral nutrition (PN) and enteral nutrition (tube feeding), cardiac/inotropic therapies, immunoglobulins (IVIg and SCIg), Alpha-1 therapies, pain and palliative care services, and hydration therapy.
  • Brand-new compounding "clean room," which is compliant with USP 797 pharmaceutical compounding standards.
  • Individual patient counseling and education.
  • Skilled nursing services for in-home infusion care.

"Coram is pleased to build upon our long-standing investment in Virginia with the opening of this new branch," said Rob Allen, President, Coram CVS/specialty infusion services. "We know that infusion care provided in the home or at an alternate site infusion suite can help promote better health and an improved quality of life for patients with complex infusion needs."

The address of the new branch is 1574 East Parham Road, Richmond, VA 23228. The branch's toll-free number is 855.276.8951; their local phone number is 804.553.3970. The branch fax number is 804.553.3971.

About Coram CVS/specialty infusion services
CoramCVS/specialty infusion services is a leading national provider of specialty home infusion and specialty pharmacy services. The integration of Coram and CVS/caremark pharmacy services, a division of CVS Caremark (NYSE: CVS), enables the company to offer more than 65 years of combined experience; enhanced, comprehensive infusion services; expanded payer access; and an expanded national footprint. Fully accredited by The Joint Commission, Coram has more than 85 locations across the country, including 65 infusion suites, ensuring both a national presence and comprehensive local coverage. Coram's nurses, pharmacists, dietitians and other clinical staff provide personalized care to thousands of home and infusion suite patients every day. For more information, please visit our website at www.coramhc.com.

Media Contact:
Christine Cramer
CVS Caremark
(401)770 3317
christine.cramer@cvscaremark.com

Logo - http://photos.prnewswire.com/prnh/20140509/86177

SOURCE CVS Caremark

Press Release
"Likes" Count
0

Coram CVS/Specialty Infusion Services Opens New Branch Pharmacy And Infusion Suite In El Paso, TX

Top of the article

WOONSOCKET, R.I., May 12, 2014 /PRNewswire/ --Coram CVS/specialty infusion services announces the opening of a new branch pharmacy in El Paso, Texas that will serve the Big Bend, Panhandle, and Permian Basin areas of Texas, as well as southern New Mexico. The new facility, which is larger than the previous branch location, offers a number of services, including:

  • Ambulatory infusion suite, which provides an alternative to a hospital setting where patients can receive IV infusion of specialty drugs in a safe, monitored environment.
  • Comprehensive offering of infusion therapies, including anti-infective services, parenteral nutrition (PN) and enteral nutrition (tube feeding), cardiac/inotropic therapies, immunoglobulins (IVIg and SCIg), Alpha-1 therapies, and pain and palliative care services.
  • Brand-new compounding "clean room," which is compliant with USP 797 pharmaceutical compounding standards.
  • Peripherally inserted central catheter (PICC) line placement using state-of-the-art technology. This new service enables infusion therapy to begin immediately, without the need for an x-ray confirmation or hospitalization.
  • Individual patient counseling and education.
  • Skilled nursing services.
  • Nursing language services available in English and Spanish.
"As the only national infusion services company in the area, Coram is pleased to build upon our long-standing investment in the El Paso community and the surrounding areas with the opening of this branch," said Rob Allen, President, Coram CVS/specialty infusion services. "We know that infusion care provided in the home or at an alternate site infusion suite can help promote better health and an improved quality of life for patients with complex infusion needs."

The address of the new branch is 3817 Constitution Drive, Suite 300, El Paso, TX 79922-1367. The branch phone number is 915.833.0140; the fax number is 915.581.9366.

An Open House will be held at the branch on Tuesday, May 13, from 12:00 noon to 5:00 pm. The event will feature tours of the new facility, in-service training for nursing staff, door prizes, and food and drinks. The event will also feature demonstrations of the branch's new PICC line placement technology the BARD Access System and the Sherlock 3CG Tip Confirmation System.

About Coram CVS/specialty infusion services
CoramCVS/specialty infusion services is a leading national provider of specialty home infusion and specialty pharmacy services. The integration of Coram and CVS/caremark pharmacy services, a division of CVS Caremark (NYSE: CVS), enables the company to offer more than 65 years of combined experience; enhanced, comprehensive infusion services; expanded payer access; and an expanded national footprint. Fully accredited by The Joint Commission, Coram has more than 85 locations across the country, including 65 infusion suites, ensuring both a national presence and comprehensive local coverage. Coram's nurses, pharmacists, dietitians and other clinical staff provide personalized care to thousands of home and infusion suite patients every day. For more information, please visit our website at www.coramhc.com.

Media Contact:
Christine Cramer
CVS Caremark
(401)770 3317
christine.cramer@cvscaremark.com

Logo - http://photos.prnewswire.com/prnh/20140509/86260

SOURCE CVS Caremark

Press Release
"Likes" Count
0

CVS Caremark Launches Innovative Specialty Connect Program at all CVS/pharmacy Locations

Top of the article

WOONSOCKET, R.I., May 28, 2014 /PRNewswire/ -- CVS Caremark (NYSE: CVS) has reinvented the specialty patient experience with Specialty Connect, a specialty prescription services program. The program leverages CVS Caremark's unique retail and specialty pharmacy resources to offer patients unsurpassed choice and flexibility in how they access their specialty medications, while providing centralized expert clinical support.

Specialty medications treat complex conditions, including hepatitis C, multiple sclerosis, psoriasis, oncology and rheumatoid arthritis, and often require special handling, storage and administration. Historically, patients faced three key challenges when filling a new prescription for a specialty medication: submitting the prescription, having easy access to centralized expert clinical and benefits support, and navigating the logistics involved in receiving the drug. For example, as many as one quarter of patients who tried to fill a specialty prescription at a traditional retail pharmacy faced barriers. These complications often resulted in delayed or abandoned treatment and added to the confusion that patients already face when managing a new or chronic condition.

Specialty Connect simplifies getting started on therapy and helps patients stay on therapy to support improved health outcomes. Patients have a new option to bring their specialty prescriptions to any CVS/pharmacy location, as a complement to existing specialty pharmacy processes. After initiating their prescriptions, patients receive insurance guidance and dedicated clinical support by phone from a team of specialty pharmacy experts, trained in each therapeutic area, who are available 24 hours a day, 365 days a year. The program also makes it easy for patients to get their specialty drugs, whether they choose between in-store pickup at any of the 7,600 CVS/pharmacy stores nationwide[1] or receive their medications via mail service delivery.

[1]In compliance with state laws in-store pickup will not be available in WV & AR.

"Specialty Connect helps specialty patients with these critical therapies by helping to eliminate common challenges they had often faced and by offering them flexibility and choice," said Alan Lotvin, M.D., Executive Vice President of Specialty Pharmacy for CVS Caremark. "The program makes it easier and more convenient for patients to submit and receive their specialty prescriptions either through CVS/pharmacy or by mail. What's more, it increases medication adherence, improves outcomes and lowers overall health care costs for specialty patients and payors."

Specialty Connect has demonstrated high levels of patient satisfaction as well as improved adherence for specialty pharmacy patients. In fact, pilot program results demonstrated a 13 percentage point increase (from 66 to 79 percent) in patients who were optimally adherent to their medication. Early program results also show that the program is improving upon the patient experience and reducing traditional barriers to getting started on medication, with 97 percent of patients successfully starting on therapy after only their first interaction at a CVS/pharmacy store. In addition, more than half of patients, many of whom were existing mail service pharmacy customers, chose to pick up their specialty medications at CVS/pharmacy.

CVS Caremark was awarded the 2014 Rx Benefit Innovation Award by the Pharmacy Benefit Management Institute (PBMI) for the Specialty Connect program.

About CVS Caremark
CVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the United States. Through the company's more than 7,600 CVS/pharmacy stores; its leading pharmacy benefit manager serving more than 64 million plan members; and its retail health clinic system, the largest in the nation with more than 800 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans. As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs by developing new approaches such as its unique Pharmacy Advisor program that helps people with chronic diseases such as diabetes obtain and stay on their medications. Find more information about how CVS Caremark is reinventing pharmacy for better health at info.cvscaremark.com.

Media Contact:
Christine Cramer
CVS Caremark
(401) 770 3317
christine.cramer@cvscaremark.com

Logo - http://photos.prnewswire.com/prnh/20090226/NE75914LOGO

SOURCE CVS Caremark

Press Release
"Likes" Count
1

CVS Health to Adopt Epic Electronic Health Record System for CVS Specialty Care Management Programs

Top of the article

WOONSOCKET, R.I., March 2, 2017 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that it has selected Epic as the electronic health record (EHR) system for CVS Specialty's care management programs. The transition to Epic will help integrate and improve clinical processes for CVS Specialty, including Accordant, which provides care management program services for patients with rare, chronic diseases. This announcement expands the Company's use of the Epic EHR system beyond MinuteClinic which transitioned to the system in 2015.

"As the specialty pharmacy of choice for many payors and patients, we are focused on creating the most clinically advanced specialty pharmacy experience to help improve care and outcomes for our patients," said Alan Lotvin, M.D. Executive Vice President of CVS Specialty. "We are pleased to transition our care management programs onto the Epic platform, which will enable immediate information sharing with other health care providers across the patient's entire care team. This connectivity is integral in providing the best possible, coordinated health."

Epic the most widely used EHR in the U.S. will support CVS Specialty's evidence-based care management programs and facilitate connectivity with health care providers nationwide that currently use Epic, including many major health systems, hospital networks and physician groups. Epic interoperability exchanges 1.3 million records daily with tens of thousands of organizations via various national and regional networks including hospitals, clinics and providers.

"By transitioning to the Epic EHR, we can further coordinate care across health care disciplines and settings, which promotes more effective and informed health care decision making," added Trip Hofer, President of Accordant.

Specialty pharmacy is one of the fastest growing health care segments in the U.S. As the largest specialty pharmacy, CVS Specialty provides advanced clinical services for eligible patients who require treatment for rare or complex conditions. This includes drug therapy management, dispensing and infusion services, in addition to customized support and counseling to help ensure appropriate and safe medication use and achieve positive health outcomes. Eligible patients receive ongoing disease education, counseling and benefits verification, as well as coordination of care with multiple health care providers, comprehensive patient education and adherence management.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Contact:

Christina Beckerman
CVS Health
(401) 770-8868
christina.beckerman@cvshealth.com

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
0